Acromegaly Update podcast

Acromegaly Update — Monday September 7, 2026

0:00
7:00
Rewind 15 seconds
Fast Forward 15 seconds
It's a thin week for acromegaly-specific research — no top-tier-journal hits, so we're covering the best next-tier evidence on GH-axis physiology, octreotide drug delivery, and pituitary imaging AI — while rare disease industry news delivers a sharp one-two: Ionis just won the first-ever approval for Alexander disease, days after Ultragenyx's marquee Angelman syndrome drug flopped in Phase 3.

More episodes from "Acromegaly Update"